Marc Rivière works as a General Partner at TVM Capital Life Science. The firm's known portfolio counts 18 companies.
Is Marc Rivière a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Focus
- BiotechClinical TrialsDiagnosticsDrug DiscoveryGenomicsMedTechMedical DevicesPharmaProject-Focused Company (PFC)SemiconductorsTelecommunicationsTherapeuticsWireless
Contacts
Affiliated funds' portfolios
General Partner at TVM Capital Life Science, whose known portfolio counts 18 companies
- CSA Medical
- Myo
- Rapid Micro Biosystems
- Argos Therapeutics
- Centogene
- Proteon Therapeutics
- Smart Reporting
- Leon Nanodrugs
- Vektor Medical
- Access Vascular
- F-Star Therapeutics
- invendo medical
- and 6 more
Investor Profile
The listing covers sectors Consumer, Hardware and Healthcare, and focus areas Biotech, Clinical Trials, Diagnostics and Drug Discovery. Startups operating in these areas may find Marc Rivière relevant.
Stage-wise, the deals at TVM Capital Life Science cluster around Growth, Late-Stage and Seed rounds.
The firm portfolio and the focus above give founders context on whether Marc Rivière matches their raise.
Colleagues at TVM Capital Life Science
Valentina Agostoni
Principal
Montreal, Canada
Stefan Fischer
Managing Partner (Finance) bei TVM Capital Life Science
Munich, Germany
Hubert Birner
Managing Partner
Munich, Germany
Sebastian Lopez
Venture Capital Professional
United Arab Emirates
Sascha Berger
Investor
Görlitz, Germany
Luc Marengere
Managing partner
Turks and Caicos Islands
Philipp Lechner
Principal
Germany
Milagre Cossa
Venture Capital & Private Equity Professional
Mozambique
Ismael Mussagy
Venture Capital & Private Equity Professional
Mozambique
Frequently asked questions
Who is Marc Rivière?
Marc Rivière is a venture capital investor based in Montreal, Quebec, Canada, listed as General Partner at TVM Capital Life Science. The known portfolio of that firm counts 18 companies. That portfolio belongs to the firm, not to Marc Rivière personally.
What does Marc Rivière invest in?
Listed sectors include Consumer, Hardware and Healthcare; listed focus areas include Biotech, Clinical Trials, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Marc Rivière invest at?
TVM Capital Life Science appears in Growth, Late-Stage and Seed rounds across its known deals, and Marc Rivière is listed there as General Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Marc Rivière listed at?
Marc Rivière is listed as General Partner at TVM Capital Life Science. 9 other people in the database share a firm with Marc Rivière.
How do I contact Marc Rivière?
An email address, a phone number and a LinkedIn page are on file for Marc Rivière. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal